Abstract

How cancer cells cope with high levels of replication stress during rapid proliferation is currently unclear. Here, we show that macrophage migration inhibitory factor (MIF) is a 3’ flap nuclease that translocates to the nucleus in S phase. Poly(ADP-ribose) polymerase 1 co-localizes with MIF to the DNA replication fork, where MIF nuclease activity is required to resolve replication stress and facilitates tumor growth. MIF loss in cancer cells leads to mutation frequency increases, cell cycle delays and DNA synthesis and cell growth inhibition, which can be rescued by restoring MIF, but not nuclease-deficient MIF mutant. MIF is significantly upregulated in breast tumors and correlates with poor overall survival in patients. We propose that MIF is a unique 3’ nuclease, excises flaps at the immediate 3’ end during DNA synthesis and favors cancer cells evading replication stress-induced threat for their growth.

Replication stress is associated with cancer formation and progression. Here the authors reveal that the macrophage migration inhibitory factor (MIF) functions as 3’ flap nuclease involved in resolving replication stress affecting overall tumor progression.

Details

Title
MIF is a 3’ flap nuclease that facilitates DNA replication and promotes tumor growth
Author
Wang, Yijie 1   VIAFID ORCID Logo  ; Chen, Yan 1 ; Wang, Chenliang 1 ; Yang, Mingming 1 ; Wang, Yanan 1 ; Bao Lei 1 ; Wang, Jennifer E 1 ; Kim BongWoo 1 ; Chan, Kara Y 2 ; Xu Weizhi 2 ; Capota Emanuela 3 ; Ortega, Janice 2   VIAFID ORCID Logo  ; Nijhawan Deepak 3 ; Guo-Min, Li 2   VIAFID ORCID Logo  ; Luo Weibo 4   VIAFID ORCID Logo  ; Wang, Yingfei 5   VIAFID ORCID Logo 

 UT Southwestern Medical Center, Department of Pathology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 UT Southwestern Medical Center, Department of Radiation Oncology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 UT Southwestern Medical Center, Department of Internal Medicine, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 UT Southwestern Medical Center, Department of Pathology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); UT Southwestern Medical Center, Department of Pharmacology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 UT Southwestern Medical Center, Department of Pathology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); UT Southwestern Medical Center, Department of Neurology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2529007686
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.